The significant role which MRPs play in chemoresistant GBM patients was identified in 1995 by Abe et al. (1994) with high grade gliomas (HGGs) showing a significant increase in expression of several MRPs including MRP1 (ABCC1). The gene discussed is MRPS7; the disease is central nervous system cancer.